Résultats de recherche

New in our A Life in Science series, we hear from Florence Meyer-Losic, Vice President and Head of Translational Sciences, about her journey from veterinary medicine to human research. She highlights the importance of adaptability, continuous lea...

Nouvelle dans notre série Une vie dans la science, nous rencontrons Eli Leo, Early Development Asset Lead, qui explique comment le travail d’équipe, la créativité et même l’échec nourrissent les progrès de la recherche. En se com...

Christelle Huguet, EVP Head of R&D...

Nouvelle dans notre série Une vie dans la science, nous rencontrons Florence Meyer-Losic, Vice President et Head of Translational Sciences, qui retrace son parcours de la médecine vétérinaire à la recherche sur l’humain. Elle souligne l...

Christelle Huguet, EVP, Directrice R&D...

New in our A Life in Science series, we hear from Audrey Clapéron, Translational Biology Director, about the essential role of data in driving discovery forward. She shares how leading a team of pharmacologists and delivering high-quality evidence for ...

New in our A Life in Science series, we hear from Elodie Lewkowicz, Asset Lead, about how curiosity and collaboration drive her mission to tackle the complexity of cancer. She reflects on mentoring, developing the next generation of scientists, and keeping...

New in our A Life in Science series, we hear from Eli Leo, Early Development Asset Lead, about how teamwork, creativity, and even failure fuel progress in research. From seeing herself as a conductor guiding scientists like an orchestra to learning from ...

“My job is to be a guardian of patient safety.”As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly....

New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development, about her path from discovering a passion for pharmacology to leading drug candidates through first-in-human trials. She shares how...